Inventor · disambiguated record
Richard T. Lewis
Also filed as: LEWIS RICHARD · LEWIS RICHARD T · LEWIS RICHARD THOMAS
45 granted patents·11 pending applications·997 citations·filing 1993–2025
98Inventor score
Top patents by PatentIndex Score
56 records- 0198US5514718AHeterocyclic compounds, processes for their preparation and pharmaceutical compositions containing themMERCK SHARP & DOHME·Filed 1994·Granted May 7, 1996·551 cites·12 claims
- 0296US11370786B2GLS1 inhibitors for treating diseaseUNIV TEXAS·Filed 2020·Granted Jun 28, 2022·6 cites·17 claims
- 0395US11958849B2GLS1 inhibitors for treating diseaseUNIV TEXAS·Filed 2022·Granted Apr 16, 2024·2 cites·12 claims
- 0494US10766892B2GLS1 inhibitors for treating diseaseUNIV TEXAS·Filed 2019·Granted Sep 8, 2020·9 cites·26 claims
- 0594US8198448B2Fused heterocyclic derivatives and methods of useALBRECHT BRIAN K·Filed 2008·Granted Jun 12, 2012·50 cites·38 claims
- 0693US11713313B2GLS1 inhibitors for treating diseaseUNIV TEXAS·Filed 2020·Granted Aug 1, 2023·3 cites·12 claims
- 0793US9809588B2GLS1 inhibitors for treating diseaseUNIV TEXAS·Filed 2015·Granted Nov 7, 2017·15 cites·27 claims
- 0893US9066954B2Fused heterocyclic derivatives and methods of useAMGEN INC·Filed 2013·Granted Jun 30, 2015·22 cites·9 claims
- 0992US10738043B2GLS1 inhibitors for treating diseaseUNIV TEXAS·Filed 2018·Granted Aug 11, 2020·6 cites·12 claims
- 1092US10344025B2GLS1 inhibitors for treating diseaseUNIV TEXAS·Filed 2017·Granted Jul 9, 2019·12 cites·11 claims
- 1192US8524900B2Fused heterocyclic derivatives and methods of useALBRECHT BRIAN K·Filed 2011·Granted Sep 3, 2013·23 cites·8 claims
- 1291US11690850B2Inhibitors of receptor interacting protein kinase I for the treatment of diseaseUNIV TEXAS·Filed 2020·Granted Jul 4, 2023·3 cites·24 claims
- 1391US10125128B2GLS1 inhibitors for treating diseaseBOARD OF REGENTS UNIV OF TEXAS SYSTEM·Filed 2016·Granted Nov 13, 2018·13 cites·21 claims
- 1486US2024360121A1Gls1 inhibitors for treating diseaseUNIV TEXAS·Filed 2024·Application pending·0 cites
- 1585US10899769B2Imidazopiperazinone inhibitors of transcription activating proteinsUNIV TEXAS·Filed 2019·Granted Jan 26, 2021·3 cites·26 claims
- 1685US6900215B2Imidazo-pyrimidine derivatives as ligands for gaba receptorsMERCK SHARP & DOHME·Filed 2002·Granted May 31, 2005·16 cites·28 claims
- 1785US6500828B1Triazolo-pyridazine derivatives as ligands for gaba receptorsMERCK SHARP & DOHME·Filed 2000·Granted Dec 31, 2002·18 cites·9 claims
- 1884US6642229B23-Phenyl-imidazo-pyrimidine derivatives as ligands for GABA receptorsMERCK SHARP & DOHME·Filed 2001·Granted Nov 4, 2003·21 cites·11 claims
- 1983US7626056B2Cyclohexanesulfonyl derivatives as GlyT1 inhibitors to treat schizophreniaMERCK SHARP & DOHME·Filed 2006·Granted Dec 1, 2009·5 cites·11 claims
- 2082US6936608B2Imidazo-triazine derivatives as ligands for GABA receptorsMERCK SHARP & DOHME·Filed 2001·Granted Aug 30, 2005·20 cites·17 claims
- 2182US5760018AGem-disubstituted azacyclic tachykinin antagonistsMERCK SHARP & DOHME·Filed 1995·Granted Jun 2, 1998·59 cites·11 claims
- 2281US11753381B2Inhibitors of receptor interacting protein kinase I for the treatment of diseaseUNIV TEXAS·Filed 2020·Granted Sep 12, 2023·1 cites·8 claims
- 2381US7825135B2Heteroaryl piperidine glycine transporter inhibitorsMERCK SHARP & DOHME·Filed 2005·Granted Nov 2, 2010·6 cites·13 claims
- 2480US11718612B2Inhibitors of receptor interacting protein kinase I for the treatment of diseaseUNIV TEXAS·Filed 2020·Granted Aug 8, 2023·1 cites·10 claims
- 2580US9556135B2Amino-dihydrothiazine and amino-dioxido dihydrothiazine compounds as beta-secretase antagonists and methods of useAMGEN INC·Filed 2013·Granted Jan 31, 2017·2 cites·38 claims
- 2679US6730676B2Pyrazino-pyridazine derivatives as ligands for GABA receptorsMERCK SHARP & DOHME·Filed 2001·Granted May 4, 2004·13 cites·9 claims
- 2778US7030128B2Imidazo-pyrimidine derivatives as ligands for GABA receptorsMERCK SHARP & DOHME·Filed 2002·Granted Apr 18, 2006·11 cites·10 claims
- 2876US12286406B2Inhibitors of receptor interacting protein kinase I for the treatment of diseaseUNIV TEXAS·Filed 2023·Granted Apr 29, 2025·0 cites·20 claims
- 2975US9096615B2Bridged bicyclic amino thiazine dioxide compounds as inhibitors of beta-secretase and methods of use thereofAMGEN INC·Filed 2014·Granted Aug 4, 2015·2 cites·32 claims
- 3073US6969716B25-phenyl[1,2,4]triazines as ligands for GABA-A α2/α3 receptors for treating anxiety or depressionMERCK SHARP & DOHME·Filed 2004·Granted Nov 29, 2005·6 cites·10 claims
- 3171US9115127B2Benzimidazole and azabenzimidazole compounds that inhibit anaplastic lymphoma kinaseBOEZIO CHRISTIANE M·Filed 2011·Granted Aug 25, 2015·2 cites·17 claims
- 3270US6133255ATricyclic pyridone analogues as GABA-A receptor ligandsMERCK SHARP & DOHME·Filed 1998·Granted Oct 17, 2000·29 cites·7 claims
- 3368US2025214942A1Inhibitors of receptor interacting protein kinase i for the treatment of diseaseUNIV TEXAS·Filed 2025·Application pending·0 cites
- 3465US5328927AHetercyclic compounds, processes for their preparation and pharmaceutical compositions containing themMERCK SHARPE & DOHME LTD·Filed 1993·Granted Jul 12, 1994·16 cites·13 claims
- 3564US5554627ATachykinin antagonistsMERCK SHARP & DOHME·Filed 1993·Granted Sep 10, 1996·8 cites·11 claims
- 3663US8716281B2Pyrimidine compounds that inhibit anaplastic lymphoma kinaseBRYAN MARIAN C·Filed 2011·Granted May 6, 2014·1 cites·41 claims
- 3763US7851638B2Cyclohexanesulfonyl derivatives as GLYT1 inhibitors to treat schizophreniaMERCK SHARP & DOHME·Filed 2009·Granted Dec 14, 2010·0 cites·9 claims
- 3863US5461063AAzabicyclic compoundsMERCK SHARP & DOHME·Filed 1993·Granted Oct 24, 1995·10 cites·12 claims
- 3958US2014107109A1Amino-dihydrothiazine and amino-dioxido dihydrothiazine compounds as beta-secretase antagonists and methods of useAMGEN INC·Filed 2013·Application pending·0 cites
- 4057US6333336B1Pyrazolo-pyridine derivatives as ligands for GABA receptorsMERCK SHARP & DOHME·Filed 1999·Granted Dec 25, 2001·13 cites·10 claims
- 4149US5811431ASpiro-substituted azacyclic derivatives and their use as therapeutic agentsMERCK SHARP & DOHME·Filed 1995·Granted Sep 22, 1998·8 cites·25 claims
- 4249US5719149AMorpholine derivatives and their use as therapeutic agentsMERCK SHARP & DOHME·Filed 1995·Granted Feb 17, 1998·8 cites·15 claims
- 4349US2003158203A1Triazolo-pyridazine derivatives as ligands for GABA receptorsMERCK & CO INC·Filed 2002·Application pending·0 cites
- 4448US11046649B2Compounds useful as inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan dioxygenaseUNIV TEXAS·Filed 2019·Granted Jun 29, 2021·0 cites·23 claims
- 4548US2016046625A1Benzimidazole and azabenzimidazole compounds that inhibit anaplastic lymphoma kinaseAMGEN INC·Filed 2015·Application pending·0 cites
- 4647US2012107275A1Fused heterocyclic derivatives and methods of useALBRECHT BRIAN K·Filed 2011·Application pending·0 cites
- 4745US8163956B2Inhibitors of GLYT1 transportersBLACKABY WESLEY PETER·Filed 2006·Granted Apr 24, 2012·0 cites·11 claims
- 4844US2006235021A1Phenylpyridazine derivatives as ligands for gaba receptorsBLACKABY WESLEY·Filed 2003·Application pending·0 cites
- 4943US7655644B2Piperidine and azetidine derivatives as GlyT1 inhibitorsMERCK SHARP & DOHME·Filed 2005·Granted Feb 2, 2010·0 cites·2 claims
- 5043US2010222317A1Azetidine Derivatives as GlyT1 InhibitorsBLACKABY WESLEY PETER·Filed 2006·Application pending·0 cites
Showing the top 50 of 56 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Richard T. Lewis files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →